News 14 Sep 2021 Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting admin
News 08 Sep 2021 Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021 admin
News 07 Sep 2021 Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference admin
News 01 Sep 2021 Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders admin
News 30 Aug 2021 Daxor Corporation Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR Filing for the Six Months Ended June 30, 2021 admin
News 04 Aug 2021 Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care admin
News 22 Jul 2021 Daxor Corporation Announces Non-Government Distribution Agreement with Concordance® Healthcare Solutions admin
News 13 Jul 2021 American College of Cardiology (ACC) Features Expert Analysis on the Importance of Addressing Anemia With Blood Volume Analysis in Heart Failure Patients admin
News 28 May 2021 Daxor Corporation to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021 admin
